Education Library

Adam Gottula, MD, discusses considerations for optimizing patient care when transporting patients supported with Impella or other mechanical circulatory support devices.

Chuck Simonton, MD, discusses the limitations of published papers that use administrative or payer databases as data sources and provides an AMI cardiogenic shock example.

Michael Galvin, BS, RDCS, discusses the role of echocardiography and Impella in cardiogenic shock.

Alexandra Lansky, MD, discusses a propensity-adjusted population-based analysis of Impella in patients undergoing high-risk PCI from a large-scale claims dataset. 

Adam Salisbury, MD, presents the primary results from the OPTIMUM Registry, a late breaker at TCT 2021.

Srihari Naidu, MD discusses updates to the SCAI shock stages at TCT 2021.

William O’Neill, MD, discusses the development of best practices for treating AMI cardiogenic shock leading to the RECOVER IV RCT.

Gregg Stone, MD, reviews evidence for the use of mechanical circulatory support during high-risk PCI and provides an overview of the PROTECT IV RCT.

Jason Wollmuth, MD, discusses large-bore access and intravascular imaging best practices for treating high-risk PCI patients.

Jeffrey Moses, MD, discusses the improved outcomes with contemporary practices seen in the PROTECT III study of Impella-supported high-risk PCI.

Navin Kapur, MD, explains the importance of identifying patients with heart failure who can be enrolled in the PROTECT IV trial.

William O’Neill, MD, discusses Protected PCI as a practical approach to mechanical circulatory support in elective complex PCI cases.

Jaime Hernandez-Montfort, MD, discusses management considerations for heart failure cardiogenic shock (HFCS) at HFSA 2021.

Navin Kapur, MD, discusses clinical evidence to support ‘on-pump’ complex PCI for patients with heart failure.

Shelley Hall, MD, discusses what can be done about cardiogenic shock and where the field is going, and issues a call for achieving heart recovery.